Moreover, IL-19 treatment can significantly reduce the up-regulation of TNF-α and IL-6 mRNA expression after ischemic stroke, inhibit the increase of microglia, macrophages, CD4+ T cells, CD8+ T cells, and B cells, and suppress the activation of macrophages and neutrophils. This evidence concerns the gene CD8A and ischemic stroke.